Singapore Creates Immunology Network To Coordinate Research
This article was originally published in PharmAsia News
The government of Singapore has established an immunology network to tie universities, hospitals and other institutions to a system of collaboration and coordination on the core subject of the country's initiative to foster biomedical science. Eventually, the network is to help create partnerships between local and international biotech and pharmaceutical companies. Those collaborations would focus on antibody platforms, immunotherapies for cancer, and development of vaccines and diagnostic for children. The research is to be divided into three areas, cancer immunology, immune disorders and immunity to infections. (Click here for more
You may also be interested in...
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This biweekly selection of insights from our experienced on-the-ground team will help.
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.